Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

16.10.2017

2 BMC Cancer
1 Br J Cancer
3 Cancer
2 Cancer Lett
1 Cancer Res
3 Dis Colon Rectum
3 Eur J Cancer
5 Eur J Surg Oncol
2 Gastroenterology
9 Gastrointest Endosc
1 Gut
2 Int J Cancer
1 Lancet Gastroenterol Hepatol
1 Lancet Oncol
5 Oncogene
5 PLoS One



    BMC Cancer

  1. ZHANG J, Ren J, Wei J, Chong CC, et al
    Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
    BMC Cancer. 2016;16:926.
    >> Share

  2. STEPPELER C, Sodring M, Paulsen JE
    Colorectal Carcinogenesis in the A/J Min/+ Mouse Model is Inhibited by Hemin, Independently of Dietary Fat Content and Fecal Lipid Peroxidation Rate.
    BMC Cancer. 2016;16:832.
    >> Share


    Br J Cancer

  3. LETELLIER E, Schmitz M, Ginolhac A, Rodriguez F, et al
    Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence.
    Br J Cancer. 2017 Oct 12. doi: 10.1038/bjc.2017.
    >> Share


    Cancer

  4. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    >> Share

  5. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    >> Share

  6. LEVI Z, Kark JD, Katz LH, Twig G, et al
    Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
    Cancer. 2017;123:4022-4030.
    >> Share


    Cancer Lett

  7. SHUKLA K, Sonowal H, Saxena A, Ramana KV, et al
    Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO1/AMPK pathway in colon cancer cells.
    Cancer Lett. 2017 Oct 3. pii: S0304-3835(17)30584.
    >> Share

  8. LIANG Z, Yang Y, He Y, Yang P, et al
    SUMOylation of IQGAP1 promotes the development of colorectal cancer.
    Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30607.
    >> Share


    Cancer Res

  9. HUANG S, Fantini D, Merrill B, Bagchi S, et al
    DDB2 is a Novel Regulator of Wnt-Signaling in Colon Cancer.
    Cancer Res. 2017 Oct 11. pii: canres.1570.2017.
    >> Share


    Dis Colon Rectum

  10. SHOAR S, Mahmoodzadeh H, Shoar N, Geilser DP, et al
    Single-Incision Laparoscopic Colectomy with Complete Mesocolic Excision Versus Multiport Laparoscopic Colectomy for Colon Cancer.
    Dis Colon Rectum. 2017;60:e631.
    >> Share

  11. SHIN CM, Han K, Lee DH, Choi YJ, et al
    Association Among Obesity, Metabolic Health, and the Risk for Colorectal Cancer in the General Population in Korea Using the National Health Insurance Service-National Sample Cohort.
    Dis Colon Rectum. 2017;60:1192-1200.
    >> Share

  12. PICKHARDT PJ, Edwards K, Bruining DH, Gollub M, et al
    Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care.
    Dis Colon Rectum. 2017;60:1162-1167.
    >> Share


    Eur J Cancer

  13. PREVOSTEL C, Blache P
    The dose-dependent effect of SOX9 and its incidence in colorectal cancer.
    Eur J Cancer. 2017;86:150-157.
    >> Share

  14. KEIKES L, Koopman M, Tanis PJ, Lemmens VEPP, et al
    Evaluating the scientific basis of quality indicators in colorectal cancer care: A systematic review.
    Eur J Cancer. 2017;86:166-177.
    >> Share

  15. SUENAGA M, Schirripa M, Cao S, Zhang W, et al
    Potential role of polymorphisms in the transporter genes ENT1 and MATE1/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer.
    Eur J Cancer. 2017;86:197-206.
    >> Share


    Eur J Surg Oncol

  16. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
    Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Eur J Surg Oncol. 2017;43:1901-1907.
    >> Share

  17. SUN Y, Xu Z, Lin H, Lu X, et al
    Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Eur J Surg Oncol. 2017;43:1828-1834.
    >> Share

  18. JONKER FHW, Hagemans JAW, Verhoef C, Burger JWA, et al
    The impact of hospital volume on perioperative outcomes of rectal cancer.
    Eur J Surg Oncol. 2017;43:1894-1900.
    >> Share

  19. KVERNENG HULTBERG D, Angenete E, Lydrup ML, Rutegard J, et al
    Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer.
    Eur J Surg Oncol. 2017;43:1908-1914.
    >> Share

  20. SOLON JG, O'Neill M, Chang KH, Deady S, et al
    An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
    Eur J Surg Oncol. 2017;43:1924-1931.
    >> Share


    Gastroenterology

  21. LEVIN TR
    Colorectal Cancer Screening: Money Isn't Everything...But it Helps!
    Gastroenterology. 2017 Oct 4. pii: S0016-5085(17)36185.
    >> Share

  22. MARINGHINI A, Maringhini M
    Gallstones and Colon Cancer: A Result of a Wrong Study Revived.
    Gastroenterology. 2017 Oct 5. pii: S0016-5085(17)36136.
    >> Share


    Gastrointest Endosc

  23. MELSON J, Berger D, Greenspan M, Bayoumi M, et al
    Maintaining low non-neoplastic polypectomy rates in high-quality screening colonoscopy.
    Gastrointest Endosc. 2017;85:581-587.
    >> Share

  24. MURAKAMI T, Sakamoto N, Ritsuno H, Shibuya T, et al
    Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma.
    Gastrointest Endosc. 2017;85:590-600.
    >> Share

  25. LEE A, Jensen CD, Marks AR, Zhao WK, et al
    Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting.
    Gastrointest Endosc. 2017;85:601-610.
    >> Share

  26. VON RENTELN D, Robertson DJ, Bensen S, Pohl H, et al
    Prolonged cecal insertion time is associated with decreased adenoma detection.
    Gastrointest Endosc. 2017;85:574-580.
    >> Share

  27. REX DK, Ponugoti P, Kahi C
    The "valley sign" in small and diminutive adenomas: prevalence, interobserver agreement, and validation as an adenoma marker.
    Gastrointest Endosc. 2017;85:614-621.
    >> Share

  28. PONUGOTI P, Lin J, Odze R, Snover D, et al
    Prevalence of sessile serrated adenoma/polyp in hyperplastic-appearing diminutive rectosigmoid polyps.
    Gastrointest Endosc. 2017;85:622-627.
    >> Share

  29. KUDO T, Kudo SE, Mori Y, Wakamura K, et al
    Classification of nuclear morphology in endocytoscopy of colorectal neoplasms.
    Gastrointest Endosc. 2017;85:628-638.
    >> Share

  30. SUGIMOTO S, Naganuma M, Iwao Y, Matsuoka K, et al
    Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement.
    Gastrointest Endosc. 2017;85:639-646.
    >> Share

  31. TATE DJ, Desomer L, Klein A, Brown G, et al
    Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool.
    Gastrointest Endosc. 2017;85:647-656.
    >> Share


    Gut

  32. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    >> Share


    Int J Cancer

  33. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    >> Share

  34. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    >> Share


    Lancet Gastroenterol Hepatol

  35. THE LANCET GASTROENTEROLOGY HE
    Improving uptake of colorectal cancer screening.
    Lancet Gastroenterol Hepatol. 2017;2:767.
    >> Share


    Lancet Oncol

  36. SEKHAR H, Zwahlen M, Trelle S, Malcomson L, et al
    Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.
    Lancet Oncol. 2017;18:1348-1359.
    >> Share


    Oncogene

  37. WANG LF, Liu YS, Yang B, Li P, et al
    The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share

  38. ROS S, Floter J, Kaymak I, Da Costa C, et al
    6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
    Oncogene. 2017;36:3287-3299.
    >> Share

  39. LI Y, Zhou T, Wang Y, Ning C, et al
    The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
    Oncogene. 2017;36:3760-3771.
    >> Share

  40. SUMNER ET, Chawla AT, Cororaton AD, Koblinski JE, et al
    Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
    Oncogene. 2017;36:4810-4816.
    >> Share

  41. WEISENBERGER DJ, Liang G, Lenz HJ
    DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    >> Share


    PLoS One

  42. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    >> Share

  43. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    >> Share

  44. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    >> Share

  45. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    >> Share

  46. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016